About Jeffrey Dunn
Jeffrey Dunn is a chairman, president & CEO at Si-Bone.
Form D filings name Jeffrey Dunn as a director at Theradaptive and Reiley Pharmaceuticals.
Jeffrey Dunn reports to the SEC as a director or officer of 1 public company.
Jeffrey Dunn first appears on SEC filings in 2014.
Experience
This experience comes from Jeffrey Dunn's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jeffrey Dunn in the role, so the role may have started earlier or lasted longer.
SI
Si-Bone, Inc.
Chairman, President & CEO
Executive Chairman
2018 – 2026 · Public company (SIBN)
Theradaptive, Inc.
Director
2026 · Frederick, MD
Develops protein-based treatments for people needing bone and tissue repair.
Key Colleagues at Startups
The people Jeffrey Dunn works with at each company, as listed on that company's latest Form D.
Theradaptive, Inc. · Form D, Aug 4, 2026
DH
David Harrington
Director
David Stewart
Chief Operating Officer and director
PZ
Patrick Zhang
Director
Luis Alvarez
Founder and CEO, director
TM
Ted Meyers
Director
GS
George Shanine
Director
Reiley Pharmaceuticals, Inc. · Form D, Jun 5, 2024